All In MedTech

FDA Clearance Tracker · P890055-S026

CODMAN 3000 SERIES IMPLANTABLE INFUSION PUMP

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 17, 2010 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 17, 2010

Approved

Time to decision

1,102 days

Received Dec 11, 2007. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P890055-S026
Device name
CODMAN 3000 SERIES IMPLANTABLE INFUSION PUMP
Applicant location
Newton, MA
Received
Dec 11, 2007
Decided
Dec 17, 2010
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P890055

Device type

Device class
Class III

Every decision under product code LKK

FDA's approval statement

As written in FDA's record.

APPROVAL FOR MEDSTREAM PROGRAMMABLE INFUSION SYSTEM. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME MEDSTREAM PROGRAMMABLE INFUSION SYSTEM AND IS INDICATED FOR CHRONIC INTRATHECAL INFUSION OF BACLOFEN INJECTION STERILE SOLUTION (5.0 PH TO 7.0 PH) IN THE TREATMENT OF SEVERE SPASTICITY.

Source documents

Other decisions for Intera Oncology

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.